Literature DB >> 26477068

[Factors Affecting Outcomes of Repeated Penetrating Keratoplasty].

Shinobu Yamamoto, Machiko Shimmura-Tomita, Yoshiyuki Satake, Seika Shimazaki-Den, Shigeto Shimmura, Jun Shimazaki.   

Abstract

PURPOSE: To investigate prognosis for repeated penetrating keratoplasty (PKP) and factors that affect the outcome.
METHODS: We retrospectively investigated graft survival rates, 1-year postoperative best-corrected visual acuity and irreversible rejection rates in 108 eyes of 106 patients that had repeated PKP. Factors that might affect the outcome were, age, number of previous PKP, original diseases, history of glaucoma and rejection and the use of postoperative immunosuppressant were also studied.
RESULTS: Individual-factor analysis showed that history of rejection and postoperative immunosuppressant significantly increased the risk of postoperative rejection. Multi-factor analysis showed that graft survival rate was significantly lower among cases that had systemic immunosuppressants (steroids and cyclosporine). One year postoperative best-corrected visual acuity was significantly worse in cases that had history of glaucoma. In cases with history of rejection, systemic administration of postoperative immunosuppressants was significantly associated with postoperative irreversible rejection.
CONCLUSION: History of rejection and glaucoma tend to have poor outcome, and the outcome might not improve by postoperative immunosuppressants.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26477068

Source DB:  PubMed          Journal:  Nippon Ganka Gakkai Zasshi        ISSN: 0029-0203


  2 in total

1.  Twelve-year follow-up of penetrating keratoplasty.

Authors:  Takashi Ono; Sosuke Ishiyama; Takeshi Hayashidera; Yosai Mori; Ryohei Nejima; Kazunori Miyata; Shiro Amano
Journal:  Jpn J Ophthalmol       Date:  2016-11-24       Impact factor: 2.447

2.  Indications and graft survival analysis in optical penetrating keratoplasty in a tertiary care center in North India: a 5-year study.

Authors:  Sudesh Kumar Arya; Amit Raj; Ravi Kant Bamotra; Anubha Bhatti; Jyoti Deswal; Meenakshi Sindhu
Journal:  Int Ophthalmol       Date:  2017-07-07       Impact factor: 2.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.